S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
CVE:MPH

Medicure Stock Forecast, Price & News

C$0.97
-0.03 (-3.00 %)
(As of 10/18/2021 11:08 AM ET)
Add
Compare
Today's Range
C$0.97
C$0.97
50-Day Range
C$0.92
C$1.20
52-Week Range
C$0.70
C$2.01
Volume500 shs
Average Volume8,231 shs
Market CapitalizationC$9.94 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive MPH News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.


About Medicure

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia; and ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure, as well as Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. The company was founded in 1997 and is headquartered in Winnipeg, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
C$15.95 million
Cash Flow
C$0.24 per share
Book Value
C$1.68 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$9.94 million
Next Earnings Date
11/10/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.13 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -












Medicure (CVE:MPH) Frequently Asked Questions

What stocks does MarketBeat like better than Medicure?

Wall Street analysts have given Medicure a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medicure wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Medicure's next earnings date?

Medicure is scheduled to release its next quarterly earnings announcement on Wednesday, November 10th 2021.
View our earnings forecast for Medicure
.

How were Medicure's earnings last quarter?

Medicure Inc. (CVE:MPH) issued its earnings results on Friday, August, 27th. The company reported ($0.06) earnings per share (EPS) for the quarter. The firm had revenue of $5.09 million for the quarter.
View Medicure's earnings history
.

How has Medicure's stock been impacted by COVID-19?

Medicure's stock was trading at C$2.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MPH stock has decreased by 51.5% and is now trading at C$0.97.
View which stocks have been most impacted by COVID-19
.

Who are Medicure's key executives?

Medicure's management team includes the following people:
  • Dr. Albert David Friesen, Founder, CEO & Chairman of the board (Age 74, Pay $330.75k)
  • Dr. Neil Owens Ph.D., Pres & COO
  • Mr. David Aaron Gurvey B.Sc., CMA, CPA, Chief Financial Officer (Age 55)
  • Dr. Reuben Saba Ph.D., VP of Scientific & Medical Affairs
  • Ms. Jamie Gowryluk, VP of Commercial Operations

What other stocks do shareholders of Medicure own?

What is Medicure's stock symbol?

Medicure trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MPH."

How do I buy shares of Medicure?

Shares of MPH and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Medicure's stock price today?

One share of MPH stock can currently be purchased for approximately C$0.97.

How much money does Medicure make?

Medicure has a market capitalization of C$9.94 million and generates C$15.95 million in revenue each year.

What is Medicure's official website?

The official website for Medicure is www.medicure.com.

Where are Medicure's headquarters?

How can I contact Medicure?

Medicure's mailing address is 1250 Waverley St Suite 2, WINNIPEG, MB R3T 6C6, Canada. The company can be reached via phone at +1-204-4877412.


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.